<DOC>
	<DOCNO>NCT01700543</DOCNO>
	<brief_summary>This post market clinical follow-up study design confirm safety performance Sidus Stem-Free Shoulder use hemi total shoulder arthroplasty . The safety implant evaluate monitoring frequency incidence kind adverse event . The performance determine analyze implant survival , overall pain functional performance ( base Constant &amp; Murley score ASES score ) , subject quality life ( EuroQol EQ5D ) radiographic parameter ( e.g . radiolucencies , osteolysis , component migration ) study subject receive Sidus Stem-Free Shoulder . The Sidus Stem-Free Shoulder approve use US .</brief_summary>
	<brief_title>Sidus ( TM ) Post Market Clinical Follow-up ( PMCF ) Study</brief_title>
	<detailed_description>This study prospective , noncontrolled , multi-center post market clinical follow-up study involve orthopedic surgeon skilled hemi total shoulder arthroplasty procedure . A total number 160 subject include study . Ethics Committee ( EC ) approval site obtain prior conduct study . Sequentially , eligible patient offer study enrollment center avoid potential selection bias . All potential subject require participate inform consent process sign EC approve write Informed Consent prior study enrollment . The study design prospective ensure study population representative type population device intend treat . Patients select accord subject selection criterion describe section 8 . All subject undergo preoperative , intraoperative immediate postoperative assessment include physical examination , radiographic evaluation collection quality life metric . Follow-up evaluation conduct 3 6 month , 1 , 2 , 5 , 7 10 year postoperation .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<criteria>Patient 18 80 year age , inclusive . The patient skeletally mature . Patient suffer severe shoulder pain disability require unilateral bilateral HSA TSA base physical exam medical history . Patient fail conservative treatment . Patient meet least one follow indication : Osteoarthritis , Posttraumatic arthrosis , Rheumatoid arthritis without humeral metaphyseal defect , Focal avascular necrosis humeral head , Previous surgery shoulder compromise fixation . Patient willing able cooperate require postoperative therapy . Patient willing able complete schedule followup evaluation describe Informed Consent . Patient participate Informed Consent process sign Ethics Committee approve `` Informed Consent '' . Patient unwilling unable give consent comply followup program . Patients condition would judgement Investigator place patient undue risk interfere study . Any patient institutionalized , know drug abuser , know alcoholic anyone understand require . Patient know pregnant breastfeeding . Patient meet least one contraindication : Soft inadequate humeral bone ( include osteoporosis extensive avascular necrosis rheumatoid arthritis ) lead poor implant fixation , Metaphyseal bony defect ( include large cyst ) , Posttraumatic tuberosity nonunion , Signs infection , Irreparable cuff tear , Revision fail stem prosthesis , Charcot 's shoulder ( neuroarthropathy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Stemless shoulder implant</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Hemi Shoulder Arthroplasty</keyword>
	<keyword>Total Shoulder Arthroplasty</keyword>
	<keyword>Prospective</keyword>
	<keyword>Multi-center</keyword>
	<keyword>Europe</keyword>
	<keyword>Non-Controlled</keyword>
	<keyword>Good Bone Stock</keyword>
</DOC>